TNFRSF1A and glaucoma: Although there are no preclinical studies for TNFR selective drugs in glaucoma, multiple observations from other neurodegenerative diseases such as AD indicate that this approach could provide neuroprotective effects while minimizing the side effects of global neutralization of TNF.